Association of PCSK9 Inhibitor Initiation on Statin Adherence and Discontinuation

BACKGROUND: PCSK9is (proprotein convertase subtilisin/kexin type 9 inhibitors) are well tolerated, potently lower cholesterol, and decrease cardiovascular events when added to statins. However, statin adherence may decrease after PCSK9i initiation and alter clinical outcomes. We evaluate the associa...

Descripción completa

Detalles Bibliográficos
Autores principales: LaFratte, Christopher, Peasah, Samuel K., Huang, Yan, Hall, Deanne, Patel, Urvashi, Good, Chester B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547275/
https://www.ncbi.nlm.nih.gov/pubmed/37702065
http://dx.doi.org/10.1161/JAHA.123.029707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547275/
https://www.ncbi.nlm.nih.gov/pubmed/37702065
http://dx.doi.org/10.1161/JAHA.123.029707

Ejemplares similares